Table 4.
Author, Year | Country | Sample Size of Infants | Time of Postpartum (Days/Weeks/Months) | BMIC 1 (µg/L) | UIC 1 (µg/L) | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Observational study | |||||||||||
Aakre et al., 2016 [22] | Algeria | 289 | 31.4 days 1 | 479 | 722 | ||||||
Anderson et al., 2010 [24] | Switzerland | 875 | 6–12 months | 49 | 82 | ||||||
Budak et al., 2009 [28] | Turkey | 35 | 5–28 days | 33 2 | 100 | ||||||
Chen et al., 2020 [30] | China | 634 | 24 weeks | 165 | 216 | ||||||
Costeira et al., 2009 [32] | Portugal | 142 | 3 months | 3 days | 95 | 3 days | 65 | ||||
3 months | 70 | 3 months | 96 | ||||||||
Chung et al., 2009 [31] | Korea | 31 | 6 weeks | 3rd week | 1153 | 3rd week | 1651 | Small sample size | |||
6th week | 822 | 6th week | 1832 | ||||||||
de Lima et al., 2013 [33] | Brazil | 33 | ≤6 months | 206 | 293 | Small sample size | |||||
Dold et al., 2017 [20] | China, Philippines and Croatia |
866 | 3 months | China (n = 298) | 170 | China (n = 298) | 278 | ||||
Philippines (n = 281) | 185 | Philippines (n = 281) | 352 | ||||||||
Croatia (n = 73) | 124 | Croatia (n = 73) | 239 | ||||||||
Dumrongwongsiri et al., 2018 [34] | Thailand | 71 | NS | 255 | 282 | ||||||
Huynh et al., 2017 [38] | Australia | 696 | 3 months | 127 | 198 | ||||||
Isiklar Ozberk et al., 2018 [39] | Turkey | 107 | NS | 97 | 95 | ||||||
Jin et al., 2021 [40] | New Zealand | 87 | 3 months | 69 | 115 | ||||||
Kart et al., 2021 [41] | Turkey | 334 | 4–6 days | 138 | 142 | ||||||
Kurtoglu et al., 2004 [43] | Turkey | 70 | 5 days | 73 | 24 | ||||||
Liu et al., 2015 [45] | China | 343 | 1 year | Beihai (I-deficient areas) (n = 103) |
41 | Beihai (I-deficient areas) (n = 28) |
65 | ||||
Yangcheng and Jiajiazhuang (I-sufficient areas) (n = 91) |
346 | Yangcheng and Jiajiazhuang (I-sufficient areas) (n = 90) |
427 | ||||||||
Pingyao and Jicun (I-excess areas) (n = 99) |
942 | Pingyao and Jicun (I-excess areas) (n = 124) |
1222 | ||||||||
Liu et al., 2020 [46] | China | 218 | 0–12 months | Suitable water iodine content areas (n = 97) | 312 | Suitable water iodine content areas (n = 97) | 427 | ||||
High water iodine content areas (n = 121) | 1006 | High water iodine content areas (n = 121) | 1222 | ||||||||
Mobasseri et al., 2014 [47] | Azerbaijan | 106 | NS | 58 | 307 | ||||||
Nazeri et al., 2018 [48] | Iran | 124 | <3 months | 100 | 183 | ||||||
Ordookhani et al., 2007 [50] | Iran | 27 | 37 to 42 weeks | 148 | 271 | Small sample size | |||||
Osei et al., 2016 [51] | South Africa | 100 | 2–4 months | 179 | 373 | ||||||
Osei et al., 2016 [52] | South Africa | 386 | 6 months | 180 | 345 | ||||||
Pal et al., 2017 [53] | India | 128 | 1–3 months | 230 | 250 | ||||||
Prpić et al., 2021 [57] | Croatia | 133 | 2–96 weeks | 121 | 2–26 weeks (n = 101) | 234 | |||||
27–96 weeks (n = 32) | 209 | ||||||||||
Skeaff et al., 2005 [59] | New Zealand | 230 | 6–24-month | 22 | 67 | ||||||
Stinca et al., 2017 [60] | Morocco | 239 | ≤8 weeks | 42 | 73 | ||||||
Vermiglio et al., 1992 [62] | Italy | 27 | 5–7 days | Endemic group (n = 11) | 33 2 | Endemic group (n = 11) | 34 2 | Small sample size | |||
Control group (n = 16) | 43 2 | Control group (n = 16) | 43 2 | ||||||||
Wang et al., 2018 [63] | China | 106 | 4–12 weeks | 4-week | 222 2 | 4-week | 251 | ||||
8-week | 175 2 | 8-week | 183 | ||||||||
12-week | 148 2 | 12-week | 164 | ||||||||
Wang et al., 2009 [64] | China | 61 | 0–1 year | 163 | 233 | ||||||
Yan et al., 2005 [65] | China | 2537 | 0–2 years | Urban | 136 | Urban | 236 | Huge study in 11 provinces of China | |||
Rural | 158 | Rural | 247 | ||||||||
Interventional study | |||||||||||
Bouhouch et al., 2014 [66] | Morocco | 241 | 0–9 months | Indirect infant supplementation | Direct infant supplementation | Indirect infant supplementation | Direct infant supplementation | One dose of 400 mg iodine as oral iodised oil soon after delivery | |||
Baseline | 41 | 43 | Baseline | 73 | 74 | ||||||
3-month | 61 | 33 | 3-month | 132 | 99 | ||||||
6-month | 49 | 36 | 6-month | 142 | 122 | ||||||
9-month | 39 | 26 | 9-month | 97 | 90 | ||||||
Gebreegziabher et al., 2017 [68] | Ethiopia | 101 | 6 months | Capsule group | I-salt group | Capsule group | I-salt group | 225 μg iodine as potassium iodide capsule daily for 6 months or 450 g of appropriately iodized salt (30–40 μg I as KIO3/g of salt) weekly for household consumption for 6 months |
|||
Baseline | 149 | 157 | Baseline | 234 | 193 | ||||||
6-month | 104 | 111 | 6-month | 254 | 195 | ||||||
Gutierrez-Repiso et al., 2014 [36] | Spain | 88 | NS | Control group (n = 21) | 109 | Control group (n = 21) | 112 | 300 µg of iodide (in the form of KI) were given from the first trimester of pregnancy (300 group) |
|||
300 group (n = 67) (300 µg) | 178 | 300 group (n = 67) (300 µg) | 215 | ||||||||
Kirk et al., 2012 [42] | United States | 13 | 1–8 months | Pre supplementation | 53 2 | Pre supplementation | 239 | Small sample size | |||
PM supplementation | 57 2 | PM supplementation | 379 | ||||||||
AM supplementation | 57 2 | AM supplementation | 324 | ||||||||
Nazeri et al., 2017 [69] | Iran | 84 | 1 month | Iodine fortified milk group (n = 40) | Control group (n = 40) | Iodine fortified milk group (n = 40) | Control group (n = 40) | 200 mL iodine fortified milk of which provided 150 µg iodine/day, started at the sixth day postpartum and lasted for four weeks |
|||
3–5 days (baseline) | 176 | 215 | 3–5 days (baseline) | 231 | 193 | ||||||
7 days | 191 | 176 | 7 days | 169 | 120 | ||||||
10 days | 217 | 162 | 10 days | 219 | 138 | ||||||
14 days | 242 | 160 | 14 days | 194 | 116 | ||||||
1 month | 210 | 142 | 1 month | 230 | 110 | ||||||
Nøhr et al., 1994 [49] | Denmark | 147 | 5 days | Baseline | 34 | Baseline | 32 | Vitamin-mineral preparations containing iodine (with a declared iodine content of 150 µg/tablet). |
|||
Not received iodine supplementation group (n = 94) | 34 | Not received iodine supplementation group (n = 94) | 32 | ||||||||
Tablets containing iodine group (n = 53) | 57 | Tablets containing iodine group (n = 53) | 61 |
1 Median used unless mean reported, 2 mean, NS, not stated. Reference no. [45] was counted more than once in Section 3.2 because it reported findings in both iodine deficient and sufficient populations.